About a-team Marketing Services
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Industry Underprepared for OTC Derivatives Trading and Market Regulation

Subscribe to our newsletter

By Ganesh Iyer, Senior Product Marketing Manager for Network Services, IPC Systems

While recent years have seen much talk of financial reforms, there has remained a distinct lack of clarity around what new regulations will mean for financial institutions. In the trading industry, the regulations that will have the biggest impact are European Market Infrastructure Regulation (EMIR) and Dodd Frank.

These regulations, designed specifically to provide greater transparency and to mitigate risk in the OTC derivatives industry, are well anticipated – but are they well prepared for?

IPC recently conducted a survey among hedge funds, investment banks, broker/dealers, exchanges and other financial institutions asking this question, as well as exploring their perceptions of the impending regulations. The responses revealed that financial institutions are underprepared to meet the requirements these regulations will place on them, even as they plan to increase their trading activity in OTC derivatives.

Trading in OTC derivatives has seen huge growth in recent years. It was unsurprising therefore to see that 94% of firms surveyed are already trading swaps or other OTC derivatives or plan to do so in the next six months. However, just 19% believed the industry as a whole was well prepared to meet the regulations. This is perhaps surprising given that 74% of respondents said they expected their firms’ trading volumes to increase in the next year. The findings reinforce what we have seen in the industry, exposing real concerns that neither individual firms nor the industry as a whole are well prepared for the impending regulations.

The industry has questioned whether the regulations will reduce systemic risk as they are intended to. However, only 29% of respondents believed that the reforms will actually result in reduced risk. More positively, 57% agreed that increased market and transaction transparency will be a major benefit resulting from the new regulations. The increased availability of market data is also recognised as an important benefit of the reforms. Worryingly, 21% of respondents felt that there could be consequences for the future of OTC derivatives trading as a result of what they perceive to be ill-conceived rules that have not taken into consideration all elements of risk.

The introduction of Swap Execution Facilities (SEFs) are a pivotal aspect of the regulations in the US. Dodd Frank defined SEFs as “a facility, trading system or platform in which multiple participants have the ability to execute or trade swaps by accepting bids and offers made by other participants that are open to multiple participants in the facility or system, through any means of interstate commerce.”

Connectivity to SEFs will be critical for trading firms, not only with regard to compliance but also to gain competitive advantage and capitalise on new opportunities. Some of the industry appears to recognise this as 39% of respondents said that their firm is connected or planning to connect with 10 SEFs or more, and 23% revealed plans to connect to over 20 SEFs. However, 34% of firms still did not have a plan in place to connect to any SEFs.

Current debate centres on whether the upheaval in the OTC derivatives market will drive traders towards the futures market, using new swap futures contracts which offer easier access to similar exposures and at a lower cost. While 66% of respondents are expecting to see a shift to the futures market, it is important to recognise that swaps were created with a specific purpose in mind. It seems more likely that the two markets will coexist, but with some swaps becoming futurised, although not every swap has an economically equivalent future. Currently swap futures do not have the liquidity or investor confidence to really challenge swaps.

With insufficient visibility into the specifics of impending OTC derivatives regulations, it is perhaps unsurprising that many firms have seemingly delayed their planning to meet the new rules. The industry expected to see the regulations detailed in full at the end of 2012, but with delays and setbacks this is now expected in the first half of 2013. Firms must be ready to act quickly to ensure their businesses, systems and processes meet the new guidelines. However, they must also recognise that connectivity to SEFs and various other execution venues will be critical not only for addressing compliance concerns, but also for gaining competitive advantage and capitalising on new opportunities.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: Executing the Migration to Cloud to Enable Scalability and Innovation

Cloud-based services and processing have become essential to financial institutions as their data management demands have become more complex and expansive. Thousands of organisations have made the jump from their limited on-premises tech stacks to the near-infinite scalability opportunities of public and private clouds. They have also been motivated by the need to modernise their...

BLOG

Bloomberg’s Kate Lee on Regulatory Data as an Operating Layer for Compliance and Reporting

Regulatory data has become a firmly established part of the control architecture of capital markets firms. As transparency rules diverge across the jurisdictions, liquidity monitoring becomes more granular, and supervisors demand stronger evidence of how figures are derived, firms are obligated to treat regulatory datasets as governed, versioned and explainable operating assets. In this Q&A...

EVENT

Data Management Summit New York City

Now in its 16th year, Data Management Summit (DMS) NYC returns on September 17th 2026, to explore how to use data and AI to drive measurable business outcomes – reliably, repeatedly and at scale.

GUIDE

AI in Capital Markets Handbook 2026

AI adoption in capital markets has moved into a more disciplined phase. The priority is now controlled deployment: where AI can be used safely, where it can deliver measurable value, and how outputs can be governed, monitored and evidenced. The 2026 edition of the AI in Capital Markets Handbook examines how AI is being applied...